ArticleGastroenterology research and practice2013

The Novel Crohn's Disease Marker Anti-GP2 Antibody Is Associated with Ileocolonic Location of Disease.

Valentina Somma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.